Table 3.
Sleep apnea in relation to lifetime days of use of carbofuran among male applicators in the ALHS*
| Sleep Apnea (N=1569) | |||||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Cases (n=234) | Non-cases (n=1335) | ||||||
|
| |||||||
| Lifetime days of use | Exposed, n (%) | Exposed, n (%) | OR† | 95% CI‡ | p-value§ | Trend p-value§ | |
| Never use | 126 (57.8) | 859 (69.5) | ref | ref | ref | ref | |
| < 14.5 | 33 (15.1) | 144 (11.7) | 1.69 | 1.06 | 2.67 | 0.03 | |
| ≥14.5 to <38.75 | 26 (11.9) | 115 (9.3) | 1.71 | 1.03 | 2.83 | 0.04 | |
| ≥38.75 | 33 (15.1) | 117 (9.5) | 1.75 | 1.08 | 2.82 | 0.02 | 0.003 |
| Missing | 16 | 100 | |||||
Definition of Abbreviation: ALHS = Agricultural Lung Health Study
Adjusted for age, state, BMI, asthma, cardiovascular disease, hypertension, diabetes
OR: odds Ratio
95% CI: 95% confidence interval
P-value, uncorrected